» Articles » PMID: 26184326

Experimental West Nile Virus Infection in Rabbits: An Alternative Model for Studying Induction of Disease and Virus Control

Overview
Journal Pathogens
Date 2015 Jul 18
PMID 26184326
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The economic impact of non-lethal human and equine West Nile virus (WNV) disease is substantial, since it is the most common presentation of the infection. Experimental infection with virulent WNV strains in the mouse and hamster models frequently results in severe neural infection and moderate to high mortality, both of which are not representative features of most human and equine infections. We have established a rabbit model for investigating pathogenesis and immune response of non-lethal WNV infection. Two species of rabbits, New Zealand White (Oryctolagus cuniculus) and North American cottontail (Sylvilagus sp.), were experimentally infected with virulent WNV and Murray Valley encephalitis virus strains. Infected rabbits exhibited a consistently resistant phenotype, with evidence of low viremia, minimal-absent neural infection, mild-moderate neuropathology, and the lack of mortality, even though productive virus replication occurred in the draining lymph node. The kinetics of anti-WNV neutralizing antibody response was comparable to that commonly seen in infected horses and humans. This may be explained by the early IFNα/β and/or γ response evident in the draining popliteal lymph node. Given this similarity to the human and equine disease, immunocompetent rabbits are, therefore, a valuable animal model for investigating various aspects of non-lethal WNV infections.

Citing Articles

Causes of morbidity and mortality in wild cottontail rabbits in the eastern United States, 2013-2022.

Weyna A, Andreasen V, Burrell C, Kunkel M, Radisic R, Goodwin C J Vet Diagn Invest. 2024; 36(5):655-665.

PMID: 38853709 PMC: 11457750. DOI: 10.1177/10406387241259000.


Marmosets as models of infectious diseases.

Herron I, Laws T, Nelson M Front Cell Infect Microbiol. 2024; 14:1340017.

PMID: 38465237 PMC: 10921895. DOI: 10.3389/fcimb.2024.1340017.


Interleukins, Chemokines, and Tumor Necrosis Factor Superfamily Ligands in the Pathogenesis of West Nile Virus Infection.

Benzarti E, Murray K, Ronca S Viruses. 2023; 15(3).

PMID: 36992514 PMC: 10053297. DOI: 10.3390/v15030806.


West Nile Virus: An Update on Pathobiology, Epidemiology, Diagnostics, Control and "One Health" Implications.

Habarugira G, Suen W, Hobson-Peters J, Hall R, Bielefeldt-Ohmann H Pathogens. 2020; 9(7).

PMID: 32707644 PMC: 7400489. DOI: 10.3390/pathogens9070589.


Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): West Nile fever.

More S, Botner A, Butterworth A, Calistri P, Depner K, Edwards S EFSA J. 2020; 15(8):e04955.

PMID: 32625621 PMC: 7009844. DOI: 10.2903/j.efsa.2017.4955.


References
1.
Busch M, Kleinman S, Tobler L, Kamel H, Norris P, Walsh I . Virus and antibody dynamics in acute west nile virus infection. J Infect Dis. 2008; 198(7):984-93. DOI: 10.1086/591467. View

2.
Smirnova N, Webb B, Bielefeldt-Ohmann H, Van Campen H, Antoniazzi A, Morarie S . Development of fetal and placental innate immune responses during establishment of persistent infection with bovine viral diarrhea virus. Virus Res. 2012; 167(2):329-36. DOI: 10.1016/j.virusres.2012.05.018. View

3.
Diamond M, Shrestha B, Marri A, Mahan D, Engle M . B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003; 77(4):2578-86. PMC: 141119. DOI: 10.1128/jvi.77.4.2578-2586.2003. View

4.
Christmas S, Meager A . Production of interferon-gamma and tumour necrosis factor-alpha by human T-cell clones expressing different forms of the gamma delta receptor. Immunology. 1990; 71(4):486-92. PMC: 1384867. View

5.
Styer L, Kent K, Albright R, Bennett C, Kramer L, Bernard K . Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog. 2007; 3(9):1262-70. PMC: 1976553. DOI: 10.1371/journal.ppat.0030132. View